Clinical Trial Update: Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Polihexanide (PHMB) eye drops for Acanthamoeba Keratitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acanthamoeba Keratitis

Drugs mentioned

• Polihexanide (PHMB) eye drops (polidexanide? wait)

Snippet

Sponsor: SIFI SpA | Conditions: Acanthamoeba Keratitis | Phase 3 | Status: COMPLETED | Results posted: 2023-08-02